Formulary conversion programs: the need for patient-specific risk assessment.
作者信息
Singh Sonal, Shrivastava Rakesh, Das Vijay
机构信息
Department of Internal Medicine, Unity Health System, Rochester, New York, USA.
出版信息
MedGenMed. 2004 Sep 14;6(3):28.
Abstract
摘要
相似文献
1
Formulary conversion programs: the need for patient-specific risk assessment.处方集转换计划：患者特异性风险评估的必要性。
MedGenMed. 2004 Sep 14;6(3):28.
2
[Interaction of cyclosporin with CSE inhibitors].[环孢素与CSE抑制剂的相互作用]
Med Monatsschr Pharm. 2006 Oct;29(10):379.
3
Statins for high-risk patients without heart disease or high cholesterol.用于无心脏病或高胆固醇的高危患者的他汀类药物。
Med Lett Drugs Ther. 2006 Jan 2;48(1225):1-3.
4
Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.一名接受心脏移植的患者在同时使用环孢素和阿托伐他汀治疗期间，因巨细胞病毒感染引发横纹肌溶解症。
J Gastroenterol Hepatol. 2004 Aug;19(8):952-3. doi: 10.1111/j.1440-1746.2004.03543.x.
5
[Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment].
Therapie. 2003 Mar-Apr;58(2):168-70. doi: 10.2515/therapie:2003026.
6
Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.阿托伐他汀与环孢素联合使用相关的横纹肌溶解症。
Ann Pharmacother. 1999 Nov;33(11):1176-9. doi: 10.1345/aph.19039.
7
Muscular adverse effects of statins.
Prescrire Int. 2003 Feb;12(63):21.
8
Atorvastatin for stroke prevention.阿托伐他汀用于预防中风。
Med Lett Drugs Ther. 2006 Sep 11;48(1243):75-6.
9
Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.与辛伐他汀和克拉霉素联合使用相关的横纹肌溶解症。
Ann Pharmacother. 2004 Apr;38(4):719. doi: 10.1345/aph.1D243. Epub 2004 Feb 13.
10
Safety of high-dose atorvastatin therapy.大剂量阿托伐他汀治疗的安全性。
Am J Cardiol. 2005 Sep 5;96(5A):69F-75F. doi: 10.1016/j.amjcard.2005.06.028.
本文引用的文献
1
Risk for myopathy with statin therapy in high-risk patients.高危患者使用他汀类药物治疗时发生肌病的风险。
Arch Intern Med. 2003 Mar 10;163(5):553-64. doi: 10.1001/archinte.163.5.553.
2
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂与横纹肌溶解：肾衰竭患者的相关考量
Curr Opin Nephrol Hypertens. 2002 Mar;11(2):123-33. doi: 10.1097/00041552-200203000-00001.
3
Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion program.大规模治疗性他汀类药物处方转换计划的降脂疗效、安全性及成本
Pharmacotherapy. 2001 Sep;21(9):1130-9. doi: 10.1592/phco.21.13.1130.34616.
4
Drug interactions and the statins.药物相互作用与他汀类药物
CMAJ. 1999 Nov 16;161(10):1281-6.
5
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
Zotero 插件